17 alpha,20 beta-dihydroxypregn-4-en-3-one,
17 alpha,20 beta-dihydroxyprogesterone,
17,20beta-dihydroxypregn-4-en-3-one,
17-DHP,
17alpha-hydroxy-20beta-dihydroprogesterone,
1662-06-2,
17-DHP,
(20R)-17,20-Dihydroxypregn-4-en-3-one,
17alpha-Hydroxy-20beta-dihydroprogesterone,
17alpha,20beta-Dihydroxypregn-4-en-3-one,
17alpha,20beta-Dihydroxyprogesterone,
17,20R-dihydroxypregn-4-en-3-one,
17alpha,20beta-Dihydroxy-4-pregnen-3-one,
Pregn-4-en-3-one, 17,20-dihydroxy-, (20R)-,
17|A,20|A-dihydroxyprogesterone,
Maturation Inducing hormone (MIF),
4-Pregnene-17alpha,20beta-diol-3-one,
17,20beta-DHP,
AC1L32L4,
SCHEMBL7063502,
CHEBI:36723,
ZINC6037056,
1266AH,
LMST02030149,
MFCD00010485,
17alpha, 20beta-Dihydroxy-4-pregnen-3-one,
J-010264,
17alpha,20beta-Dihydroxy-4-pregnen-3-one, crystalline,
(8R,9S,10R,13S,14S,17R)-17-hydroxy-17-[(1R)-1-hydroxyethyl]-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one,
C21H32O3,
4-Pregnen-17alpha,20beta-diol-3-one,
CID107701,
17,20beta-dihydroxypregn-4-en-3-one,
C21-H32-O3,
17 alpha,20 beta-dihydroxyprogesterone,
17 alpha,20 beta-dihydroxypregn-4-en-3-one,
C04518,
C021012,